NCT04702178 - A Clinical Trial of COVAC-2 in Healthy Adults | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 10, 2021

Primary Completion Date

November 2, 2022

Study Completion Date

November 2, 2022

Conditions

Severe Acute Respiratory Syndrome Coronavirus 2

Interventions

BIOLOGICAL

COVAC-2

Intramuscular vaccine against SARS-CoV-2

BIOLOGICAL

Saline Placebo

Intramuscular injection of saline placebo

Trial Locations (2)

Canadian Center for Vaccinology, Dalhousie University, Halifax

Royal University Hospital, Saskatoon

All Listed Sponsors

collaborator

Government of Canada

OTHER_GOV

collaborator

Government of Saskatchewan

OTHER_GOV

collaborator

Vaccine Formulation Institute (VFI)

UNKNOWN

collaborator

Seppic

INDUSTRY

lead

University of Saskatchewan

OTHER